A carregar...
Long‐term fostamatinib treatment of adults with immune thrombocytopenia during the phase 3 clinical trial program
Two randomized, double‐blind, placebo‐controlled studies demonstrated responses (≥50 000/μL) to fostamatinib in adults with long‐standing immune thrombocytopenia (ITP). The long‐term safety and efficacy of fostamatinib were evaluated in a follow‐on, open‐label extension (OLE) study. Patients receive...
Na minha lista:
| Publicado no: | Am J Hematol |
|---|---|
| Main Authors: | , , , , , , , |
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado em: |
John Wiley & Sons, Inc.
2019
|
| Assuntos: | |
| Acesso em linha: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6594140/ https://ncbi.nlm.nih.gov/pubmed/30784097 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/ajh.25444 |
| Tags: |
Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!
|